Annual accounts receivable:
$225.73M+$148.95M(+194.00%)Summary
- As of today (May 30, 2025), ASTH annual accounts receivable is $225.73 million, with the most recent change of +$148.95 million (+194.00%) on December 31, 2024.
- During the last 3 years, ASTH annual accounts receivable has risen by +$215.13 million (+2027.95%).
- ASTH annual accounts receivable is now at all-time high.
Performance
ASTH Accounts receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly accounts receivable:
$241.08M+$15.35M(+6.80%)Summary
- As of today (May 30, 2025), ASTH quarterly accounts receivable is $241.08 million, with the most recent change of +$15.35 million (+6.80%) on March 31, 2025.
- Over the past year, ASTH quarterly accounts receivable has increased by +$120.97 million (+100.72%).
- ASTH quarterly accounts receivable is now at all-time high.
Performance
ASTH Quarterly accounts receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Accounts receivable Formula
Accounts Receivable = Total Credit Sales − Amount Collected from Credit Sales
ASTH Accounts receivable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +194.0% | +100.7% |
| 3 y3 years | +2028.0% | +336.1% |
| 5 y5 years | +1951.4% | +1238.4% |
ASTH Accounts receivable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +2028.0% | at high | +385.7% |
| 5 y | 5-year | at high | +3098.3% | at high | +3315.7% |
| alltime | all time | at high | >+9999.0% | at high | >+9999.0% |
ASTH Accounts receivable History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | $241.08M(+6.8%) |
| Dec 2024 | $225.73M(+194.0%) | $225.73M(+70.7%) |
| Sep 2024 | - | $132.24M(-0.1%) |
| Jun 2024 | - | $132.32M(+10.2%) |
| Mar 2024 | - | $120.11M(+56.4%) |
| Dec 2023 | $76.78M(+54.7%) | $76.78M(-19.9%) |
| Sep 2023 | - | $95.89M(+43.3%) |
| Jun 2023 | - | $66.93M(-15.3%) |
| Mar 2023 | - | $79.00M(+59.2%) |
| Dec 2022 | $49.63M(+367.9%) | - |
| Dec 2022 | - | $49.63M(-28.5%) |
| Sep 2022 | - | $69.39M(+3.2%) |
| Jun 2022 | - | $67.26M(+21.7%) |
| Mar 2022 | - | $55.28M(+421.1%) |
| Dec 2021 | $10.61M(+50.3%) | $10.61M(-43.4%) |
| Sep 2021 | - | $18.75M(+13.4%) |
| Jun 2021 | - | $16.54M(+0.6%) |
| Mar 2021 | - | $16.45M(+133.0%) |
| Dec 2020 | $7.06M(-35.9%) | $7.06M(-61.3%) |
| Sep 2020 | - | $18.26M(+3.8%) |
| Jun 2020 | - | $17.59M(-2.4%) |
| Mar 2020 | - | $18.01M(+63.7%) |
| Dec 2019 | $11.00M(+42.3%) | $11.00M(-44.2%) |
| Sep 2019 | - | $19.73M(+18.1%) |
| Jun 2019 | - | $16.71M(+151.6%) |
| Mar 2019 | - | $6.64M(-14.1%) |
| Dec 2018 | $7.73M(+1.7%) | $7.73M(-89.0%) |
| Sep 2018 | - | $70.08M(+102.9%) |
| Jun 2018 | - | $34.54M(-34.6%) |
| Mar 2018 | - | $52.81M(+987.2%) |
| Dec 2017 | $7.60M(+38.1%) | - |
| Sep 2017 | - | $4.86M(-10.4%) |
| Jun 2017 | - | $5.42M(-1.5%) |
| Mar 2017 | $5.51M | $5.51M(-8.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2016 | - | $5.99M(+30.8%) |
| Sep 2016 | - | $4.58M(+14.5%) |
| Jun 2016 | - | $4.00M(+17.9%) |
| Mar 2016 | $3.39M(-10.8%) | $3.39M(-7.2%) |
| Dec 2015 | - | $3.65M(-9.0%) |
| Sep 2015 | - | $4.02M(+8.7%) |
| Jun 2015 | - | $3.69M(-2.9%) |
| Mar 2015 | $3.80M(+152.0%) | $3.80M(+8.4%) |
| Dec 2014 | - | $3.51M(+4.1%) |
| Sep 2014 | - | $3.37M(+120.0%) |
| Jun 2014 | - | $1.53M(+1.4%) |
| Mar 2014 | $1.51M(-0.1%) | - |
| Jan 2014 | $1.51M(-4.6%) | $1.51M(+2.3%) |
| Oct 2013 | - | $1.48M(+3.5%) |
| Jul 2013 | - | $1.43M(+8.0%) |
| Apr 2013 | - | $1.32M(-16.6%) |
| Jan 2013 | $1.58M(+59.2%) | $1.58M(+19.6%) |
| Oct 2012 | - | $1.32M(+32.6%) |
| Jul 2012 | - | $998.30K(-12.9%) |
| Apr 2012 | - | $1.15M(+15.3%) |
| Jan 2012 | $994.10K(+41.0%) | $994.10K(+12.3%) |
| Oct 2011 | - | $885.20K(+24.9%) |
| Jul 2011 | - | $708.60K(+2.3%) |
| Apr 2011 | - | $692.40K(-1.8%) |
| Jan 2011 | $705.00K(+54.1%) | $705.00K(+9.6%) |
| Oct 2010 | - | $643.10K(+3.3%) |
| Jul 2010 | - | $622.70K(-4.7%) |
| Apr 2010 | - | $653.70K(+42.9%) |
| Jan 2010 | $457.50K(+78.9%) | $457.50K(+9.8%) |
| Oct 2009 | - | $416.60K(+25.9%) |
| Jul 2009 | - | $331.00K(+23.0%) |
| Apr 2009 | - | $269.20K(+5.3%) |
| Jan 2009 | $255.70K | $255.70K(+69.4%) |
| Oct 2008 | - | $150.90K |
FAQ
- What is Astrana Health annual accounts receivable?
- What is the all time high annual accounts receivable for Astrana Health?
- What is Astrana Health annual accounts receivable year-on-year change?
- What is Astrana Health quarterly accounts receivable?
- What is the all time high quarterly accounts receivable for Astrana Health?
- What is Astrana Health quarterly accounts receivable year-on-year change?
What is Astrana Health annual accounts receivable?
The current annual accounts receivable of ASTH is $225.73M
What is the all time high annual accounts receivable for Astrana Health?
Astrana Health all-time high annual accounts receivable is $225.73M
What is Astrana Health annual accounts receivable year-on-year change?
Over the past year, ASTH annual accounts receivable has changed by +$148.95M (+194.00%)
What is Astrana Health quarterly accounts receivable?
The current quarterly accounts receivable of ASTH is $241.08M
What is the all time high quarterly accounts receivable for Astrana Health?
Astrana Health all-time high quarterly accounts receivable is $241.08M
What is Astrana Health quarterly accounts receivable year-on-year change?
Over the past year, ASTH quarterly accounts receivable has changed by +$120.97M (+100.72%)